+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Drug Delivery Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5483452
  • Report
  • November 2021
  • Region: Global
  • 143 Pages
  • IMARC Group

FEATURED COMPANIES

  • 3M Company
  • Acrux Limited
  • Lavipharm S.A.
  • LEAD CHEMICAL Co. Ltd.
  • Luye Pharma Group
  • Nutriband Inc.
The global transdermal drug delivery systems market exhibited moderate growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

The transdermal drug delivery system (TDDS) is an alternative system of delivering drugs through the skin for systemic distribution. It is used as an alternative to oral intravascular, subcutaneous, and transmucosal routes. TDDS supports both chronic and acute diseases as well as cosmetic procedures as it delivers biologically active agents, such as drugs and cosmeceuticals, through the skin. It offers a controlled release of drugs, which reduces the first-pass metabolism effects, lessens the side effects, and improves the efficacy of the dosage by enabling a steady blood drug profile throughout the treatment.

Transdermal Drug Delivery System Market Trends:

The global transdermal drug delivery systems market is primarily driven by the growing instances of chronic disorders that cannot be treated through conventional drug delivery systems, such as oral drugs. Patients with long-term ailments, such as diabetes, are shifting toward self-administration of medicine. As a result, there has been an introduction of adhesive skin patches to administer the daily course of medication without the pain. This has encouraged patients and physicians to prefer pain-free drug delivery systems. Besides this, the wide adoption of third-generation transdermal drug delivery systems like iontophoresis promotes self-reliance in patients since it reduces frequent visits to hospitals and lessens the cumulative treatment costs. Furthermore, technological advancements, such as the inclusion of microneedles, modifications in transdermal patch designs and the incorporation of pressure-sensitive adhesives and permeation enhancers, are providing vast opportunities to manufacturers.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global transdermal drug delivery systems market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology and application.

Breakup by Technology:

  • Electroporation
  • Radiofrequency
  • Iontophoresis
  • Microporation
  • Thermal
  • Mechanical Arrays
  • Ultrasound
  • Others

Breakup by Application:

  • Central Nervous System
  • Pain Management
  • Cardiovascular
  • Hormone
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

Key Questions Answered in This Report:

  • How has the global transdermal drug delivery systems market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global transdermal drug delivery systems market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transdermal drug delivery systems market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Acrux Limited
  • Lavipharm S.A.
  • LEAD CHEMICAL Co. Ltd.
  • Luye Pharma Group
  • Nutriband Inc.
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Transdermal Drug Delivery Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Technology
6.1 Electroporation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Radiofrequency
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Iontophoresis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Microporation
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Thermal
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Mechanical Arrays
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Ultrasound
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast

7 Market Breakup by Application
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pain Management
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cardiovascular
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Hormone
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 3M Company
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Acrux Limited
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Boehringer Ingelheim International GmbH
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Hisamitsu Pharmaceutical Co. Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Lavipharm S.A.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 LEAD CHEMICAL Co. Ltd.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Luye Pharma Group
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 Nutriband Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Viatris Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials

List of Figures
Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2020
Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2020
Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2020
Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2020
Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis

List of Tables
Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players
Note: Product cover images may vary from those shown
  • 3M Company
  • Acrux Limited
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co. Inc.
  • Lavipharm S.A.
  • LEAD CHEMICAL Co. Ltd.
  • Luye Pharma Group
  • Nutriband Inc.
  • Viatris Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...